Cell-based Phototheranostics

Publications

W. Jia, J. M. Burns, B. Villantay, J. C. Tang, R. Vankayala, B. Lertsakdadet, B. Choi, J. S. Nelson, and B. Anvari, “Intravital vascular phototheranostics and real-time circulation dynamics of micro- and nano-sized erythrocyte-derived carriers,” ACS Applied Materials & Interfaces, 12, 275-287, 2020.

 

R. Vankayala*, J. T. Mac*, J. M. Burns, E. Dunn, S. Carroll, E. M. Bahena, D. K. Patel, S. Griffey, and B. Anvari, “Biodistribution and toxicological evaluation of micron- and nano-sized erythrocyte-derived optical particles in healthy Swiss Webster mice,” Biomaterials Science, 7, 2123-2133, 2019 (*equally contributed).

 

J. M. Burns, R. Vankayala, J. T. Mac, and B. Anvari, “Erythrocyte-derived theranostic nanoplatforms for infrared fluorescence imaging and photodestruction of tumors,” ACS Applied Materials & Interfaces, 10, 27621-27630, 2018.

 

B. Bahmani, D. Bacon, and B. Anvari, “Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications,” Scientific Reports, 3, 2180, DOI: 10.1038/srep02180, 2013.

GRants

Erythrocyte-derived optical nano-probes for image-guided identification of tumor margins and cancer resection, National Cancer Institute, SBIR Phase I grant, 1R43-CA210715.

 

Erythrocyte-derived nanoparticles for light activated combination of chemo-photothermal therapy of tumors, National Cancer Institute, SBIR Phase I grant, R43 CA235945.